Skip to main content
AAN.com
Articles
August 1, 1990

Longitudinal evaluation of dementia of the Alzheimer type
A comparison of 3 standardized mental status examinations

August 1990 issue
40 (8) 1225

Abstract

We administered 3 commonly employed tests of mental status (the Information-Memory-Concentration test [IMC], the Mini-Mental State Examination [MMSE], and the Dementia Rating Scale [DRS]) to 92 patients with probable dementia of the Alzheimer type. The 3 tests were readministered to 55 of the patients (2-year subgroup) approximately 1 year later, and administered a 3rd time to 20 of the patients (3-year subgroup) approximately 2 years after their initial assessment. In all cases, scores on the 3 tests were highly correlated with each other. Examination of the annual rate of change (ARC) in score for the 2-year subgroup revealed an average decline of—3.24 error points on the IMC, 2.81 points on the MMSE, and 11.38 points on the DRS. Of the 3 tests, only the DRS evidenced greater sensitivity to change with increasing dementia severity. In the 3-year subgroup, the ARC between years 1 and 2 was not correlated with ARC between years 2 and 3 for any of the 3 tests. This finding suggests that a patient's rate of progression in 1 year may bear little relationship to future rate of decline.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 40Number 8August 1990
Pages: 1225
PubMed: 2381530

Publication History

Published online: August 1, 1990
Published in print: August 1990

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

David P. Salmon, PhD
From the Departments of Neurosciences (Drs. Salmon, Thal, and Heindel) and Psychiatry (Dr. Butters), University of California School of Medicine at San Diego; and the Neurology (Dr. Thal) and Psychology Services (Drs. Salmon, Butters, and Heindel), San Diego Veterans Administration Medical Center, San Diego, CA.
Leon J. Thal, MD
From the Departments of Neurosciences (Drs. Salmon, Thal, and Heindel) and Psychiatry (Dr. Butters), University of California School of Medicine at San Diego; and the Neurology (Dr. Thal) and Psychology Services (Drs. Salmon, Butters, and Heindel), San Diego Veterans Administration Medical Center, San Diego, CA.
Nelson Butters, PhD
From the Departments of Neurosciences (Drs. Salmon, Thal, and Heindel) and Psychiatry (Dr. Butters), University of California School of Medicine at San Diego; and the Neurology (Dr. Thal) and Psychology Services (Drs. Salmon, Butters, and Heindel), San Diego Veterans Administration Medical Center, San Diego, CA.
William C. Heindel, PhD
From the Departments of Neurosciences (Drs. Salmon, Thal, and Heindel) and Psychiatry (Dr. Butters), University of California School of Medicine at San Diego; and the Neurology (Dr. Thal) and Psychology Services (Drs. Salmon, Butters, and Heindel), San Diego Veterans Administration Medical Center, San Diego, CA.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Improving fluid identification in well logging using Continuous Wavelet Transform and Vision Transformers: An innovative approach, Physics of Fluids, 36, 10, (2024).https://doi.org/10.1063/5.0221990
    Crossref
  2. Olfactory function, neurofilament light chain, and cognitive trajectory: A 12‐year follow‐up of the Shanghai Aging Study, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 15, 4, (2023).https://doi.org/10.1002/dad2.12485
    Crossref
  3. Therapeutic approaches to age-associated neurocognitive disorders, Dialogues in Clinical Neuroscience, 3, 3, (191-213), (2022).https://doi.org/10.31887/DCNS.2001.3.3/rohara
    Crossref
  4. Clinical Outcome Measure Crosswalks in Alzheimer’s Disease: A Systematic Review, Journal of Alzheimer's Disease, 83, 2, (591-608), (2021).https://doi.org/10.3233/JAD-210060
    Crossref
  5. ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study, Alzheimer's Research & Therapy, 13, 1, (2021).https://doi.org/10.1186/s13195-020-00750-y
    Crossref
  6. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors, Bioorganic Chemistry, 113, (105009), (2021).https://doi.org/10.1016/j.bioorg.2021.105009
    Crossref
  7. Cost-effectiveness of a non-pharmacological treatment vs. “care as usual” in day care centers for community-dwelling older people with cognitive impairment: results from the German randomized controlled DeTaMAKS-trial, The European Journal of Health Economics, 21, 6, (825-844), (2020).https://doi.org/10.1007/s10198-020-01175-y
    Crossref
  8. Responder Analysis of a Multicomponent Non-Pharmacological Intervention (MAKS) for People With Cognitive Impairment in the German Day-Care Study (DeTaMAKS), Frontiers in Psychiatry, 10, (2019).https://doi.org/10.3389/fpsyt.2019.00587
    Crossref
  9. Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial, Trials, 20, 1, (2019).https://doi.org/10.1186/s13063-019-3741-5
    Crossref
  10. Effects of 6-month at-home transcranial direct current stimulation on cognition and cerebral glucose metabolism in Alzheimer's disease, Brain Stimulation, 12, 5, (1222-1228), (2019).https://doi.org/10.1016/j.brs.2019.06.003
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Figures

Tables

Media

Share

Share

Share article link

Share